Bionic Sight LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD (NCT07158775) | Bionic Sight LLC | 2026-01-08 |
| BS01 in Patients With Retinitis Pigmentosa (NCT04278131) | Bionic Sight LLC | 2020-02-06 |
Track Bionic Sight LLC automatically
Every clearance here is in the API, with alerts when new ones post.